Your browser doesn't support javascript.
loading
Abatacept for Severe Immune Checkpoint Inhibitor-Associated Myocarditis.
Salem, Joe-Elie; Allenbach, Yves; Vozy, Aurore; Brechot, Nicolas; Johnson, Douglas B; Moslehi, Javid J; Kerneis, Mathieu.
Affiliation
  • Salem JE; Sorbonne Université, Paris, France joe-elie.salem@aphp.fr.
  • Allenbach Y; Sorbonne Université, Paris, France joe-elie.salem@aphp.fr.
  • Vozy A; Sorbonne Université, Paris, France joe-elie.salem@aphp.fr.
  • Brechot N; Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Johnson DB; Vanderbilt University Medical Center, Nashville, TN.
  • Moslehi JJ; Vanderbilt University Medical Center, Nashville, TN.
  • Kerneis M; Assistance Publique-Hôpitaux de Paris, Paris, France.
N Engl J Med ; 380(24): 2377-2379, 2019 06 13.
Article in En | MEDLINE | ID: mdl-31189043
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Programmed Cell Death 1 Receptor / Abatacept / Antineoplastic Agents, Immunological / Nivolumab / Myocarditis Type of study: Risk_factors_studies Limits: Aged / Female / Humans Language: En Journal: N Engl J Med Year: 2019 Type: Article Affiliation country: France
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Programmed Cell Death 1 Receptor / Abatacept / Antineoplastic Agents, Immunological / Nivolumab / Myocarditis Type of study: Risk_factors_studies Limits: Aged / Female / Humans Language: En Journal: N Engl J Med Year: 2019 Type: Article Affiliation country: France